ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 87 filers reported holding ANTARES PHARMA INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $513,000 | +15.0% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $446,000 | -2.0% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $455,000 | -16.5% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $545,000 | +6.0% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $514,000 | +3.0% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $499,000 | +47.6% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $338,000 | -1.7% | 125,000 | 0.0% | 0.00% | -50.0% |
| Q2 2020 | $344,000 | +16.6% | 125,000 | 0.0% | 0.00% | +100.0% |
| Q1 2020 | $295,000 | -49.8% | 125,000 | 0.0% | 0.00% | -50.0% |
| Q4 2019 | $588,000 | +40.7% | 125,000 | 0.0% | 0.00% | +100.0% |
| Q3 2019 | $418,000 | +1.7% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $411,000 | +8.4% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $379,000 | +11.5% | 125,000 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $340,000 | -19.0% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $420,000 | +30.0% | 125,000 | 0.0% | 0.00% | +100.0% |
| Q2 2018 | $323,000 | +17.5% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $275,000 | +10.4% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $249,000 | -38.5% | 125,000 | 0.0% | 0.00% | -50.0% |
| Q3 2017 | $405,000 | +0.5% | 125,000 | 0.0% | 0.00% | -33.3% |
| Q2 2017 | $403,000 | +13.5% | 125,000 | 0.0% | 0.00% | +50.0% |
| Q1 2017 | $355,000 | +22.0% | 125,000 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $291,000 | +20.2% | 125,000 | -13.2% | 0.00% | 0.0% |
| Q3 2016 | $242,000 | -27.3% | 144,000 | -47.6% | 0.00% | -33.3% |
| Q4 2015 | $333,000 | -28.8% | 275,000 | 0.0% | 0.00% | -25.0% |
| Q3 2015 | $468,000 | -18.2% | 275,000 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $572,000 | -23.2% | 275,000 | 0.0% | 0.00% | -33.3% |
| Q1 2015 | $745,000 | +5.4% | 275,000 | 0.0% | 0.01% | +20.0% |
| Q4 2014 | $707,000 | +39.4% | 275,000 | -0.7% | 0.01% | +25.0% |
| Q3 2014 | $507,000 | -31.5% | 277,000 | 0.0% | 0.00% | -33.3% |
| Q2 2014 | $740,000 | -26.8% | 277,000 | 0.0% | 0.01% | -33.3% |
| Q1 2014 | $1,011,000 | – | 277,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sargent Investment Group, LLC | 3,096,355 | $8,422,000 | 5.18% |
| JW Asset Management, LLC | 1,920,524 | $5,224,000 | 3.85% |
| Healthcare Value Capital, LLC | 250,000 | $680,000 | 2.64% |
| ARMISTICE CAPITAL, LLC | 10,300,000 | $28,016,000 | 2.12% |
| Broadfin Capital, LLC | 3,444,147 | $9,368,000 | 1.23% |
| PERKINS CAPITAL MANAGEMENT INC | 409,000 | $1,112,000 | 0.86% |
| MYCIO WEALTH PARTNERS, LLC | 1,896,500 | $5,158,000 | 0.48% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 1,012,600 | $2,754,000 | 0.22% |
| FALCON POINT CAPITAL, LLC | 130,200 | $354,000 | 0.21% |
| Brown Advisory Securities, LLC | 275,000 | $781,000 | 0.15% |